MedTrace Logo

Radiotherapy to the Primary in Metastatic Non-small Cell Lung Cancer Patients

NCT04776083 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2024-09-19

No results posted yet for this study

Summary

study the effect of radiotherapy to the primary lesion after first line systemic therapy in metastatic non-small cell lung cancer patients.

Conditions

  • Non-Small Cell Carcinoma of Lung, TNM Stage 4
  • Radiation Therapy

Interventions

DRUG

first line systemic therapy

first line systemic therapy according to the genetic mutation 0f the patient

RADIATION

3D radiotherapy or IMRT

Hypo-fractionated radiotherapy to the primary lesion

Sponsors & Collaborators

  • Menoufia University

    lead OTHER

Principal Investigators

  • Yostena Mekhail, M.Sc · Menoufia University

  • Eman AR Tawfeek, MD · Menoufia University

  • Enas AB Elkhouly, MD · Menoufia University

  • Reham A Abdel Aziz, MD · Menoufia University

  • Ahmed Sohaib, MD · Menoufia University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-25
Primary Completion
2023-11-25
Completion
2023-11-25

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04776083 on ClinicalTrials.gov